loadpatents
name:-0.016259908676147
name:-0.010412931442261
name:-0.0036630630493164
Shirai; Fumiyuki Patent Filings

Shirai; Fumiyuki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shirai; Fumiyuki.The latest application filed is for "novel dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor".

Company Profile
3.10.13
  • Shirai; Fumiyuki - Wako JP
  • SHIRAI; Fumiyuki - Wako-shi JP
  • Shirai; Fumiyuki - Tokyo JP
  • SHIRAI; Fumiyuki - Osaka JP
  • Shirai, Fumiyuki - Osaka-shi JP
  • Shirai; Fumiyuki - Ikeda JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compound or pharmaceutically acceptable salt thereof
Grant 11,414,429 - Yoshida , et al. August 16, 2
2022-08-16
Anticancer Agent
App 20210060016 - SEIMIYA; Hiroyuki ;   et al.
2021-03-04
Novel Dihydroquinazolinone Compound Or Pharmacologically Acceptable Salt, And Cell Growth Inhibitor
App 20210061789 - YOSHIDA; Minoru ;   et al.
2021-03-04
Novel Compound Or Pharmaceutically Acceptable Salt Thereof
App 20200172554 - YOSHIDA; Minoru ;   et al.
2020-06-04
Nitrogen-containing bicyclic aromatic heterocyclic compound
Grant 9,585,889 - Nakajima , et al. March 7, 2
2017-03-07
Nitrogen-containing Bicyclic Aromatic Heterocyclic Compound
App 20160228442 - Nakajima; Yutaka ;   et al.
2016-08-11
Nitrogen-containing bicyclic aromatic heterocyclic compound
Grant 9,328,118 - Nakajima , et al. May 3, 2
2016-05-03
Nitrogen-containing Bicyclic Aromatic Heterocyclic Compound
App 20150126488 - Nakajima; Yutaka ;   et al.
2015-05-07
Pyrazinyl hydroxyacrylamide compounds having an inhibitory effect on the activity of histone deacetylase
Grant 7,750,155 - Shirai , et al. July 6, 2
2010-07-06
N-hydroxyacrylamide Compounds
App 20100069388 - Inoue; Yoshikazu ;   et al.
2010-03-18
HDAC inhibitor
Grant 7,557,127 - Ishibashi , et al. July 7, 2
2009-07-07
Hdac Inhibitor
App 20090054464 - ISHIBASHI; Naoki ;   et al.
2009-02-26
N-hydroxyacrylamide Compounds
App 20090054465 - Shirai; Fumiyuki ;   et al.
2009-02-26
HDAC inhibitor
Grant 7,465,731 - Ishibashi , et al. December 16, 2
2008-12-16
Pyrazole Derivatives
App 20070112037 - SHIRAI; Fumiyuki ;   et al.
2007-05-17
Pyrazole derivatives
Grant 7,183,306 - Shirai , et al. February 27, 2
2007-02-27
HDAC inhibitor
App 20060052599 - Ishibashi; Naoki ;   et al.
2006-03-09
Pyrazole derivatives
App 20040116475 - Shirai, Fumiyuki ;   et al.
2004-06-17
Novel crystal of cephalosporin compound
App 20010056089 - Kawabata, Kohji ;   et al.
2001-12-27
Novel Crystal Of Cephalosporin Compound
App 20010007903 - KAWABATA, KOHJI ;   et al.
2001-07-12
1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
Grant 5,286,721 - Murata , et al. * February 15, 1
1994-02-15
1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
Grant 5,102,877 - Murata , et al. April 7, 1
1992-04-07
Crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-c arboxylic acid (syn isomer)
Grant 4,935,507 - Takaya , et al. June 19, 1
1990-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed